Founding Rogel Cancer Center Director reflects on how cancer evolved from ‘the least scientific discipline’ to a shining example of how basic research discoveries can change clinical care.

New findings about the impact of IV ketamine on treatment resistant depression add more fuel to the potential for broader use and insurance coverage.

New study has identified an enzyme contributing to systemic sclerosis.

Bacteria in the mouth may play a role in survival from idiopathic pulmonary fibrosis (IPF).

Scientists link dozens of new genome sites to coronary artery disease risk and pioneer a powerful method for illuminating the biological roots of common disease.